Style | Citing Format |
---|---|
MLA | Fekrirad Z, et al.. "Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy." Cancers, vol. 14, no. 15, 2022, pp. -. |
APA | Fekrirad Z, Barzegar Behrooz A, Ghaemi S, Khosrojerdi A, Zarepour A, Zarrabi A, Arefian E, Ghavami S (2022). Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. Cancers, 14(15), -. |
Chicago | Fekrirad Z, Barzegar Behrooz A, Ghaemi S, Khosrojerdi A, Zarepour A, Zarrabi A, Arefian E, Ghavami S. "Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy." Cancers 14, no. 15 (2022): -. |
Harvard | Fekrirad Z et al. (2022) 'Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy', Cancers, 14(15), pp. -. |
Vancouver | Fekrirad Z, Barzegar Behrooz A, Ghaemi S, Khosrojerdi A, Zarepour A, Zarrabi A, et al.. Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy. Cancers. 2022;14(15):-. |
BibTex | @article{ author = {Fekrirad Z and Barzegar Behrooz A and Ghaemi S and Khosrojerdi A and Zarepour A and Zarrabi A and Arefian E and Ghavami S}, title = {Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy}, journal = {Cancers}, volume = {14}, number = {15}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Fekrirad Z AU - Barzegar Behrooz A AU - Ghaemi S AU - Khosrojerdi A AU - Zarepour A AU - Zarrabi A AU - Arefian E AU - Ghavami S TI - Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy JO - Cancers VL - 14 IS - 15 SP - EP - PY - 2022 ER - |